Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SAFESKIN -- Ignore unavailable to you. Want to Upgrade?

To: David Rubin who wrote (480)	12/4/1998 3:07:00 PM
From: Mr. Happy	Respond to of 828

I am still looking for positive news within the years that should move the stock higher - these guys have a lot of good things in the works. I would not be short SFSK. Mr. Happy

To: David Rubin who wrote (480)	12/4/1998 4:29:00 PM
From: Short A. Few	Read Replies (1) \| Respond to of 828

Would have been nice to be short last month! I still think the big downdraft was influenced primarily by one or two institutions, selling into what is routinely a strong part of SFSKs quarterly cycle (never was able to hear what Level II info showed, though). Next, Barrons jumps in with a real cheap shot, after the stock has already become oversold. Just can't convince me that 80% ROE, 30% sales growth, and 40% earnings growth won't pull this stock back close to $35 following next two earnings reports. (So I made the ultimate mistake and got my girlfriend bought in at 19 1/2 <vbg>) Maybe as the Barrons metoo article fades into history a couple of real analysts (sorry for oxymoron) will start putting reality back into the price. Unless all that brand-new competition Barrons mentioned is more than the usual baloney (but I doubt it). I can't see them blowing out estimates, but I can see them continuing to show annual earnings increasing from $1.30 Please continue with your thoughts! regards, Short